We are live on
!
Find out more
NVPX
Norwest Venture Partners XI Portfolio holdings
AUM
$32.1M
1-Year Est. Return
15.68%
This Fund
S&P 500
This Quarter
Est. Return
+25.47%
1 Year Est. Return
+15.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$32.1M
AUM Growth
-$36.5M
(-53%)
Cap. Flow
-$50.1M
Cap. Flow
% of AUM
-156.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$50.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Health Catalyst
HCAT
$120M
| $32.1M | 100% |
876,045
-1,476,046
| -63% | -$50.1M |
|
Similar funds
AI
MCG
M
CCCPI
CRM
MTB
RA
SC
Norwest Venture Partners XI's Q3 2020 Portfolio in Review
As of Q3 2020, Norwest Venture Partners XI held 1 position worth $32.1M, down 53% from $68.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Norwest Venture Partners XI withdrew a net $50.1M in Q3 2020, reducing 1 holding. Its largest reduction was Health Catalyst, cutting an estimated $50.1M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Norwest Venture Partners XI's biggest Q3 2020 reduction was Health Catalyst, cutting an estimated $50.1M.
- Norwest Venture Partners XI's ten largest holdings make up 100% of its $32.1M portfolio in Q3 2020.
- Norwest Venture Partners XI opened 0 new positions and closed 0 in Q3 2020.
- Norwest Venture Partners XI's portfolio value fell 53% quarter-over-quarter to $32.1M.
Based on Norwest Venture Partners XI's 13F filing for Q3 2020, filed 23 Oct 2020.